LinkedIn image ad examples

Jenny Streets was called “bossy” or “too much” long before anyone recognized it as leadership. After years of working with executive coaches, she’s learned that sometimes that was just her style. And other times, it was a gender norm at play. Some rules are never written down, but we follow them anyway. So we asked women we admire to name the one rule that snuck in without their permission and rewrite it into what they believe now. Jenny Streets, NA Group Lead, CPG, Financial Services & Health at Meta, rewrote this rule: ❌ Be yourself, but don’t be “too much.” ✅ Know when to adjust your volume, but never dim your light. 🔆 What’s one inherited rule you’re ready to rewrite? Tell us in the comments 👇 Download the free Rewrite Guide 👉 https://lnkd.in/gxRWc27U #PermissionProject #WeBelieveInBetter #UnwrittenRules #WBIB #MentalHealthMatters

Looking for the next premium addition to your health portfolio? myBioma works with distributors and health businesses that want to bring advanced microbiome testing to their customers without developing the underlying scientific and technical infrastructure themselves. During our Black Month, we're opening a limited onboarding window for selected new White Label partners, with preferential conditions and discounts available throughout the campaign. You bring the market and customer relationships. We provide the testing, microbiome expertise and digital infrastructure behind the product.

¿Eres neurólogo o neurocirujano? Este simposio es para ti 🧠 Hospital Angeles Pedregal te invita al Simposio de Movimientos Anormales, un encuentro académico para actualizar conocimientos e intercambiar experiencias sobre el abordaje de trastornos del movimiento, como la enfermedad de Parkinson, el temblor de intención y la distonía. 📅 22 de octubre de 2026 🕓 16:00 a 20:30 h 👉🏻Comparte este post con tus colegas y regístrate aquí: https://lnkd.in/gv5TsfFQ #EnfermedadDeParkinson #ActualizaciónMédica #Neurología #Neurocirugía #HospitalAngeles

Could APAC be the difference between hitting your Oncology development milestones on time... or falling six months behind? In our latest webinar, Luke S. Gill, Head of Oncology, Will Chen, Global Head of Regulatory Affairs, together with Dr. Rokoyo Nochi of EPS, explored how early integration of China and Japan into global Oncology programs can accelerate enrolment, strengthen development strategies, and reduce timeline risk. Key insights shared ; ✅ The impact of China and Japan on enrolment timelines ✅ Why APAC should be considered at protocol design, not as a rescue strategy ✅ Regulatory developments enabling more seamless global studies ✅ The role of Japan and China in accelerated Oncology development pathways Read the article and discover how a dual-engine APAC strategy could help de-risk and accelerate your next Oncology program. https://lnkd.in/euiUhqsT #OncologyTrials #ClinicalResearch #OncologyDrugDevelopment #GlobalTrials #APAC #ChinaClinicalTrials #JapanClinicalTrials #ClinicalDevelopment #CRO #EmeraldClinical

Why is AI critical in Pharmaceutical Quality Management? Discover below 👇

Cancer accounted for roughly 35% of all new FDA drug approvals in 2025. Yet progress across oncology remains uneven. Where new therapies emerge depends on more than clinical need. The biology must offer a viable point of intervention, clinical evidence must be feasible to generate, and the development path must be capable of sustaining the investment required to reach patients. Rare cancers bring these pressures into particularly sharp focus. Collectively, they account for approximately one quarter of cancer diagnoses worldwide, yeat each individual disease may affect only a small number of patients. This can make research, trial recruitment, and development more difficult even where unmet need is substantial. Orphan-drug frameworks were created to change part of that equation. Through development incentives and closer regulatory engagement, they can make focused development programs viable for patient populations that may not fit conventional large-market models. Our latest blog article examines why some areas of oncology remain underserved, how biology, clinical development, and economics interact, and how orphan-drug policy has reshaped what is possible in smaller patient populations. It also looks at one setting where these challenges converge: relapse after allogeneic stem cell transplantation in acute leukemia, an area Helix BioPharma is actively targeting through its development pipeline. Read the full article: https://lnkd.in/eQU8JGbp #Oncology #CancerResearch #CancerBiology #TranslationalMedicine #MedicalInnovation #HealthcareInnovation #FutureOfMedicine #Biotechnology #LifeSciences

Contact us today to learn how our Clinical Technology Specialist team can support your cases using your equipment >> https://lnkd.in/gUcWDyvw Utilize our per-case service model with dedicated support from our experienced Clinical Technology Specialists (CTS), who operate your equipment to ensure optimal performance during each case. Our highly trained CTS team is available to assist in the OR, running a broad array of equipment and supporting your team to help drive better patient outcomes. Consider ultrasound technology — it provides real-time imaging to visualize anatomy and guide procedures. Our Clinical Technologists are skilled in optimizing image quality and making on-the-spot adjustments to ensure the best possible visualization during surgery. #AdvancedSurgicalTechnologies #ClinicalProceduralSupport #AccessForAll

What can the right clinical supply partner help make possible for your next study? At ChinaTrials 18, R&D leaders from China, Asia-Pacific, the U.S. and Europe will come together to share ideas and build partnerships. Catalent will be there too, ready to talk about flexible, comprehensive clinical supply services that can help support your studies. Come find us at Booth #5 in Shanghai, October 28–30. We’d love to hear what you’re working on. Book a 1:1 with our experts: https://lnkd.in/dY8RcKqH #ChinaTrials #ClinicalTrials #ClinicalSupply

𝐍𝐞𝐭𝐰𝐞𝐫𝐤𝐛𝐞𝐡𝐞𝐞𝐫𝐝𝐞𝐫 𝐈𝐂𝐓 𝐠𝐞𝐳𝐨𝐜𝐡𝐭! | 𝐀𝐧𝐭𝐨𝐧𝐢𝐮𝐬 𝐒𝐧𝐞𝐞𝐤 (𝟑𝟐 - 𝟑𝟔 𝐮𝐮𝐫) Als Netwerkbeheerder ICT beheer en beveilig je de netwerkinfrastructuur van ons ziekenhuis in Sneek. Je werkt met Fortigate-firewalls, WLAN en alles daartussen. Daarnaast bouw je mee aan wat komt: we vervangen op dit moment onze accesslaag en ons datacenternetwerk. Je werkt in een klein team met korte lijnen en ruimte voor je eigen ideeën. ✅ 32–36 uur, vaste aanstelling ✅ € 3.903 – € 5.503 bruto per maand ✅ Eindejaarsuitkering en een uitgebreide onboarding 👉 Solliciteer nu!

🌍 65 countries and counting and we’ve just reached an exciting new milestone! Papua New Guinea is now part of the bookdialysis network. 🎉 We’re proud to partner with Pacific International Hospital, adding two clinics in Port Moresby and Lae and marking our first presence in Papua New Guinea. Known for its tropical climate, dramatic landscapes, remarkable biodiversity and rich cultural heritage, Papua New Guinea opens up a whole new corner of the world for people on dialysis to consider exploring. Because every new country on our network means more than another point on the map. It means more choice, more possibilities and more of the world within reach. Welcome to the bookdialysis network, Pacific International Hospital PNG . 🌏 👉https://lnkd.in/gBNeykSV

At bookdialysis, we aim to make dialysis travel simpler for patients while providing clinics with a clearer, more direct way to connect with international travellers. Through bookdialysis, patients can discover your clinic and submit treatment requests as part of their travel planning. For clinics, this means greater visibility among international patients, new opportunities to receive treatment requests and the chance to become part of a growing global network. By bringing patients and clinics closer together, we help make dialysis travel more accessible and support more people in exploring the world with confidence. Join the bookdialysis network. 👉https://lnkd.in/de3WDdbu #bookdialysis #holidaydialysis #traveldialysis

Are you working with 3Shape® and our UCAN Mill materials? Then we have good news for you: the corresponding material DMEs are now available for download on our website, making it quick and easy to integrate our materials into your digital workflow. ✅ Fast access to material data ✅ Easy integration into 3Shape® ✅ Streamlined laboratory workflows ✅ Available directly on our website ➡️ Download now and get started right away. https://lnkd.in/esavvgkF

Your healthcare data is growing. Is your infrastructure keeping up? Connecting multiple EHRs, clinical systems, and data sources shouldn't mean rebuilding your infrastructure every time you scale. Kodjin Data Platform helps healthcare organizations consolidate fragmented data into a unified, scalable foundation for interoperability, analytics, research, and AI. Explore how to make your healthcare data work across systems and use cases.

When a resident declines, the F-tags leave two options. The facility failed, or the decline was unavoidable. To show unavoidable, you need evidence. Watch the on-demand video on what that evidence looks like, from admission on. #FTags #SNFCompliance #RiskManagement #NursingHomeQuality

Know affinity, ELISA, Olink or Somalogic platforms, but less familiar with mass spectrometry? The two work in fundamentally different ways, and that affects what each can measure. This guide explains the difference in plain terms and compares discovery MS, targeted LC-MS and IP-MS with affinity platforms across seven criteria. Download the free guide below.

How confident are you in the numbers behind your next go/no-go decision? Targeted LC-MS and affinity platforms take very different approaches to quantification, and that affects what you can compare across studies, sites and time points. This guide explains how the platforms differ on quantitation, specificity and reproducibility. Download the free guide below.

Great bedside care is not enough on its own. The standard of care also needs documentation and communication. When a family expects more than the standard of care, that gap can still lead to complaint visits and litigation. Watch the on-demand video on how to close it. #SkilledNursing #StandardOfCare #RiskManagement #SNFLeadership

Download our Capabilities Guide to explore comprehensive genomics, transcriptomics, proteomics, and analysis solutions for clinical and research applications.

We deliver reliable results the first time with high-quality multi-omic services and expert support. Learn more in our Capabilities Guide.

𝗪𝗮𝗻𝗻𝗲𝗲𝗿 𝗶𝘀 𝘂𝗶𝘁𝘀𝘁𝗿𝗮𝗹𝗲𝗻𝗱𝗲 𝗻𝗲𝗸𝗽𝗶𝗷𝗻 𝗺𝗲́𝗲́𝗿 𝗱𝗮𝗻 𝗲𝗲𝗻 𝗸𝗹𝗮𝗰𝗵𝘁 𝗱𝗶𝗲 𝘃𝗮𝗻𝘇𝗲𝗹𝗳 𝗼𝘃𝗲𝗿𝗴𝗮𝗮𝘁? Patiënten met pijn die vanuit de nek uitstraalt, ziet u met enige regelmaat. Bij de meesten verdwijnen de klachten binnen enkele maanden vanzelf. Soms is er echter sprake van een sluipende beschadiging van het ruggenmerg door slijtage in de nek. Die aandoening wordt vaak pas laat herkend, en een NHG-standaard is er niet. Hoe maakt u het onderscheid? In deze interactieve nascholing nemen orthopedisch wervelkolomchirurg Robert Jan Kroeze en neuroloog Andreas Tiel Groenestege u mee van anatomie naar spreekkamer. Bekijk het volledige programma en meld u aan.

𝗢𝗼𝗴𝗸𝗹𝗮𝗰𝗵𝘁 𝗶𝗻 𝗱𝗲 𝗽𝗿𝗮𝗸𝘁𝗶𝗷𝗸: 𝘀𝗽𝗼𝗲𝗱 𝗼𝗳 𝗻𝗶𝗲𝘁? Een patiënt die minder scherp leest. Rechte lijnen die ineens golven. Hoe onderscheidt u droge van natte maculadegeneratie, en welke visusklacht moet vandaag nog gezien worden? Of de vraag wanneer een premiumlens geschikt is. Oogklachten komen vaak eerst bij u binnen. In deze nascholing krijgt u handvatten voor triage en voor het gebruik van de Amslerkaart. Ook hoort u welke verwijsinformatie oogartsen graag van u ontvangen. Zo verwijst u gericht en kunt u uw patiënt vertellen wat er daarna gebeurt. Bekijk het volledige programma en meld u aan.

𝗔𝗽𝗼𝘁𝗵𝗲𝗸𝗲𝗿𝘀 𝗸𝗿𝗶𝗷𝗴𝗲𝗻 𝘃𝗲𝗿𝗴𝗼𝗲𝗱𝗶𝗻𝗴 𝘃𝗼𝗼𝗿 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘁𝗿𝗼𝘂𝘄𝗴𝗲𝘀𝗽𝗿𝗲𝗸𝗸𝗲𝗻 Therapietrouwgesprekken door apothekers worden in Noord-Limburg bij wijze van proef vergoed. Apotheker Erna Mombarg legt uit wat deze gesprekken opleveren. “Ik krijg uit het hele land van collega’s reacties: ‘Hoe heb je dit voor elkaar gekregen?’” 𝘓𝘦𝘦𝘴 𝘩𝘦𝘵 𝘨𝘦𝘩𝘦𝘭𝘦 𝘢𝘳𝘵𝘪𝘬𝘦𝘭 𝘰𝘱 𝘋𝘖𝘘: https://lnkd.in/etxsAxQk Auteur Marc de Leeuw #zorgprofessionals

Pour ses 20 ans, le #Pasteurdon célèbre « le lien » et voit encore plus grand ! Le #Pasteurdon, c’est le moment où nous nous rappelons que l’Institut Pasteur nous appartient à tous. En effet, avec ses 140 ans d’histoire, ses 10 Prix Nobel et sa recherche d’excellence dans tous les champs de la science biomédicale, l’Institut Pasteur dépend majoritairement de la générosité du public pour vivre et rester performant dans la compétition mondiale. Grâce aux dons, nous pouvons recruter les meilleures scientifiques au monde et les équiper des meilleures technologies. Et nous pouvons surtout rester libres de choisir nos recherches et de nous consacrer aux questions qui comptent : futures pandémies, impact du changement climatique sur la santé, compréhension de l’origine des cancers et des maladies du cerveau… Cette année, le #Pasteurdon a 20 ans. Pour cet anniversaire, nous avons voulu voir grand, renouveler les formats et surtout renforcer le lien entre la recherche et le public, à travers : 🔹 Un nouveau film de marque, « Le Lien », réalisé par Valentin Guiod et produit par BIRTH pour The Good Company avec la chanson « Cette guerre » de Ben Mazué, gracieusement cédée à l’Institut ; 🔹 Un nouveau parrain, Kyan Khojandi, qui met son talent et sa notoriété au service du #Pasteurdon, après Kad Merad et Julia Vignali ; 🔹 20 villes ambassadrices, dont Ville de Paris, Ville de Lyon et Ville de Bordeaux, qui relaient et soutiennent le #Pasteurdon localement ; 🔹 Des partenariats renforcés avec France Télévisions et Groupe TF1, notamment autour de la semaine du #Pasteurdon et du « Pasteurday » ; 🔹 Une soirée de prestige, ce jeudi 8 octobre à l’Institut Pasteur, animée par Julian Bugier, avec de nombreuses personnalités, dont Francoise Barre-Sinoussié-Sinoussi, Erik Orsenna, Marie NDiaye et Emmanuel Grégoire ; 🔹 Le « Pasteurday », le samedi 10 octobre 2026 à l’Institut Pasteur, une journée portes ouvertes pour faire découvrir aux enfants et aux familles les métiers de la recherche biomédicale et susciter des vocations ! Toutes ces nouveautés ont une même ambition : faire du #Pasteurdon un moment de mobilisation plus large, plus visible et plus proche de toutes et tous. Car la recherche ne peut avancer sans le soutien de la société, qui a besoin de comprendre, de partager et de soutenir la recherche. Un immense merci à toutes les équipes, tous les partenaires, toutes les personnalités, toutes les villes et, bien sûr, tous les donateurs qui font vivre cette mobilisation depuis 20 ans. 👉 Pour soutenir la recherche de l’Institut Pasteur : www.pasteurdon.fr Vos dons protègent la recherche. La recherche protège la vie. Merci et bravo à Charlyne Burban Charlotte Tanésie Mazel Elena Ioannou Antoine Cerf Mathieu Fortoul Kadidia Siméon Margot Provot Hervé Bichot Arnaud Galès Sacha Tembe Myriam Rebeyrotte Aurélien Coustillac Jeanne Fenouil et les équipes communication interne et du Centre de conférence ! https://lnkd.in/eYakNT-k

Join our live webinar to discover AI agents that are ready to integrate into your lab today. These agents are already working inside labs. They run on real lab data and connect to the systems your team already uses, so you can see how agentic AI fits into a modern, connected lab. Watch them in action, then bring your questions for the live Q&A. Tuesday, November 17th, 2026 07:00 AM PT | 10:00 AM ET | 3:00 PM GMT Save your seat 👇